Congress:
EuroSafe Imaging 2021
Keywords:
Breast, Cardiovascular system, Radioprotection / Radiation dose, CT, Radiation effects, Radiation safety, Radiobiology, Epidemiology, Workforce
Authors:
G. Frija, E. Cardis, M. Benderitter, R. Coppes, J. Damilakis, G. Flux, I. THIERRY-CHEF, U. MAYERHOFER-SEBERA
DOI:
10.26044/esi2021/ESI-14476
Methods or background
The 57-month MEDIRAD project aims to enhance the scientific bases and clinical practice of radiation protection in the medical field and thereby addresses the need to better understand and evaluate the health effects of low-dose ionising radiation exposure from diagnostic and therapeutic imaging and from off-target effects in radiotherapy.
MEDIRAD is coordinated by EIBIR (AT) with Prof. Elisabeth Cardis as Scientific Coordinator (ISGlobal, ES) and Prof. Guy Frija as Clinical Coordinator (Université de Paris, FR).
The MEDIRAD key research objectives are summarised in three pillars:
- Pillar 1: Development of innovative tools to increase the efficiency of future radiation protection research activities and support good clinical practice;
- Pillar 2: Improvement of the understanding of low-dose ionising radiation risks associated with major medical radiation procedures;
- Pillar 3: Development of recommendations based on research results and establishment of information exchange infrastructures to facilitate consensus;
The MEDIRAD Project consists of six interdependent and complementary work packages (WP) vital to the project's success.